piracetam has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 2 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "He presented with severe myoclonus, which was resistant to conventional therapy and dramatically improved after administration of 12-18 gm/die piracetam." | 1.33 | Suppression of myoclonus in SCA2 by piracetam. ( Barbieri, F; de Falco, A; De Michele, G; De Rosa, A; Filla, A; Rinaldi, C; Striano, P; Striano, S; Tucci, T, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Orsucci, D | 1 |
| Ienco, EC | 1 |
| Rocchi, A | 1 |
| Siciliano, G | 1 |
| Mancuso, M | 1 |
| Bonuccelli, U | 1 |
| De Rosa, A | 1 |
| Striano, P | 1 |
| Barbieri, F | 1 |
| de Falco, A | 1 |
| Rinaldi, C | 1 |
| Tucci, T | 1 |
| Striano, S | 1 |
| Filla, A | 1 |
| De Michele, G | 1 |
2 other studies available for piracetam and Autosomal Dominant Cerebellar Ataxia, Type II
| Article | Year |
|---|---|
Levetiracetam-responsive myoclonus in spinocerebellar ataxia type 15.
Topics: Anticonvulsants; Female; Humans; Inositol 1,4,5-Trisphosphate Receptors; Levetiracetam; Mutation; My | 2013 |
Suppression of myoclonus in SCA2 by piracetam.
Topics: Adult; Ataxia; Ataxins; Dose-Response Relationship, Drug; Gait Ataxia; Humans; Infusions, Intravenou | 2006 |